Innovative Drug Firms Want More Sting As Turkey Moves To End Patent Penalty Limbo
This article was originally published in PharmAsia News
Executive Summary
Turkey’s parliament is drafting a new patent bill to end three years of legal limbo caused by a Supreme Court decision to scrap a decree on penalties, leaving the law without a bite. Industry worries the new bill won’t be enough to deter illegal copies and plans to lobby for higher penalties, including jail sentences.